May 5, 2017 (Toronto, ON) – The molecules he works with are so small they can’t be seen with the naked eye, but for Professor Paul Santerre, who is being honoured with the 2017 Governor General’s Innovation Award, it’s what you do with those molecules that counts.

One of six awardees to be recognized at a special ceremony at Rideau Hall on May 23rd, Santerre’s award recognizes his sweeping entrepreneurial vision for scientific inquiry — and its vital role in shaping Canada’s innovation economy.

He is one of the world’s leading biomaterials researchers and a professor in the Faculty of Dentistry and the Institute of Biomaterials & Biomedical Engineering (IBBME) at the University of Toronto. Santerre is also a lead researcher at the Translational Biology and Engineering Program, part of the Ted Rogers Centre for Heart Research.

“We’d like to congratulate Professor Santerre for winning the University of Toronto’s first-ever Governor General’s Innovation Award,” said Vivek Goel, the university’s vice-president of research and innovation. “This is a wonderful recognition of his cutting-edge research and his efforts to bring those innovations to market, enabling Canadians and others to lead healthier lives.”

One of Santerre’s most successful inventions is Endexo™, a surface-modifying, flexible material that can be applied to medical equipment to solve several key medical challenges. For example, it can prevent blood from sticking and clotting to surfaces when manufactured into medical tubing — one of the major reasons for catheter failure —without the need for blood-thinning drugs. Santerre commercialized Endexo and other surface-modifying molecules through U of T start-up company Interface Biologics, Inc. (IBI). Now in its sixteenth year, IBI has three distinct molecule-based technology platforms that can be applied to hundreds of different products, with an estimated potential worth in the billions.

Broken Hearts and Bone Tape       

Useful for far more than medical devices, Santerre’s surface-modifying technologies are designed to work in harmony with the body’s natural repair processes.

With a collaborative team at the Ted Rogers Centre for Heart Research, Santerre was recently awarded a three-year, $600,000 Collaborative Health Research Project grant to continue to develop a biodegradable cardiac patch. Adapted from the same basic concepts underlying his surface modifying molecules, the patch persuades damaged cardiac tissues to re-form while it slowly degrades into materials that the body can easily flush. Importantly, the materials in the patch will calm immune responses — preventing fibrotic scar tissue from forming on the heart — and reduce the risk of heart failure.

Yet another application of the technology could revolutionize how complicated craniofacial fractures are repaired. Rather than surgically inserting plates and metal screws into the head and face, a ceramic-based “bone tape” that promotes bone growth could be applied to fracture sites. Surgeons will be able to apply this ceramic-based bone tape directly to fractures without the added need for glue, screws or pins. Like with the heart patch, the materials are designed to calm immune responses and slowly biodegrade as new bone forms, ensuring better cosmetic outcomes as well as faster healing times.

“This is invention spinning off invention,” Santerre said, crediting his success as a researcher in part to the collaborative and cross-disciplinary culture being fostered by the university and its partnerships, such as that formed between Sick Kids, UHN, and U of T to create the Ted Rogers Centre for Heart Research, where Santerre’s lab is located. “It’s truly amazing to watch. When visitors come here they can’t believe its collaborative nature,” he added.

A Hub of Innovation

In addition to his own growing company, Santerre has been guiding his students in commercializing their discoveries through start-up companies, such as the recently founded Polumiros Inc., which is developing its first product for market: a non-inflammatory, biodegradable “tissue filler” for replacing breast tissue after breast cancer surgeries. Santerre also helps to mentor more than 70 trainee-based startup companies across U of T in his role as co-director of the Faculty of Medicine’s Health Innovation Hub (H2i).

For Santerre, the H2i Hub and the other eight accelerators presently active on campus points to a seismic shift in Canada’s intellectual institutions, as the university aligns itself with entrepreneurship. It’s a move he views as critical to Canada’s economic development and its ability to compete in the global health care and innovation industries.

Health care represents the world’s largest and fastest growing economic market, contributing as much as $1 out of every $5 to the GDP in North America. But while Canada — Toronto in particular — is poised to become a world leader in this growth industry, Santerre points out that this can’t be accomplished without major investment from Canadian universities.

“The argument that academia should steer away from contributing to applied knowledge with an entrepreneurial perspective is no longer as tenable as it once was,” said Santerre, who was awarded the NSERC Synergy Award for Innovation in 2012, the Ernest C. Manning Innovation Award’s Principal Award in 2014, and U of T’s prestigious Connaught Innovation Award earlier this year.

“I extend to Paul my most sincere congratulations on this well-deserved honour,” said Daniel Haas, Dean of the Faculty of Dentistry. “This award is a recognition of Paul’s ingenuity and drive to bring the University of Toronto, and by extension, Canada, to the forefront of the innovation industries through its applied and clinical research, and a direct reflection of his enormous impact.”

“Professor Santerre’s outstanding research and inventions are a brilliant example of how multidisciplinary collaboration can address complex challenges and help people live longer, healthier lives,” said Cristina Amon, Dean of the Faculty of Applied Science & Engineering. “On behalf of the Faculty, my warmest congratulations to him on this richly deserved and prestigious recognition.”

Now in its second year, the Governor General Innovation Awards program recognizes “trailblazers and creators” who contribute to a culture of innovation in Canada.

A full list of the Governor General Innovation Award winners can be found here:


Combining the rigours of biological and clinical research with a superior educational experience across a full range of undergraduate and graduate programs – with and without advanced specialty training – the Faculty of Dentistry at the University of Toronto has earned an international reputation as a premier dental research and training facility in Canada. From the cutting-edge science of biomaterials and microbiology, to next-generation nanoparticle and stem cell therapies, to ground-breaking population and access-to-care studies, the mission of the Faculty of Dentistry is to shape the future of dentistry and promote optimal health by striving for integrity and excellence in all aspects of research, education and clinical practice.  / @UofTDentistry


The Ted Rogers Centre for Heart Research aims to develop new diagnoses, treatments and tools to prevent and individually manage heart failure – Canada’s fastest growing cardiac disease. Enabled by an unprecedented gift of $130 million from the Rogers family, the Centre was jointly conceived by its three partner organizations: The Hospital for Sick Children, University Health Network, and the University of Toronto. Together, they committed an additional $139 million toward the Centre – representing a $270 million investment in basic science, translational and clinical research, innovation, and education in regenerative medicine, genomics, and the clinical care of children and adults. It is addressing heart failure across the lifespan. / @trogersresearch

– 30-

For media inquiries, contact:

Erin Vollick, Faculty of Dentistry
Email: [email protected]
416-979-4900 x. 4381

Jeff Jurmain, Ted Rogers Centre for Heart6 research
Email: [email protected]
Tel: (416) 946-8305
Mobile: (647) 293-3414